
DOES THE A9285G POLYMORPHISM IN COLLAGEN
TYPE XII α1 GENE ASSOCIATE WITH THE RISK OF
ANTERIOR CRUCIATE LIGAMENT RUPTURES? Ficek K, Stepien-Slodkowska M, Kaczmarczyk M, Maciejewska-Karlowska A, Sawczuk M,
Cholewinski J, Leonska-Duniec A, Zarebska A, Cieszczyk P, Zmijewski P, *Corresponding Author: Piotr Zmijewski, Ph.D., Institute of Sport, Department of Physiology, Trylogii 2/16, 01-982
Warsaw, Poland. Tel.: +48-228340812. Fax: +480228350977. E-mail: piotr.zmijewski@insp.waw.pl page: 41
|
MATERIALS AND METHODS
Study Subjects. A total of 91 male football
players (23 ± 3 years) with surgically diagnosed primary
ACL ruptures who qualified for ligament reconstruction,
were recruited for this study through
Galen Orthopaedics, Bieruń, Poland. The control
group comprised 143 apparently healthy, male football
players (25 ± 2.6 years), of the same ethnicity,
a similar age category, and a comparable level of
exposure to ACL injury, who were without any selfreported
history of ligament or tendon injury.
Ethics Committee. The study was conducted
in accordance with the ethical standards as described
by Kruk [19]. Additionally, the Pomeranian Medical
University (Szczecin, Poland) Ethics Committee
approved the details of this study and all related informational
and consent documentation before any
data collection. In accordance with the Pomeranian
Medical University Ethics Committee’s guidelines,
the investigator informed all the subjects as to the
benefits and possible risks associated with participation
in the study, and all subjects signed a written
informed consent document indicating their voluntary
participation.
Genotyping. Genomic DNA was extracted
from the oral epithelial cells using GenElute Mammalian
Genomic DNA Miniprep Kit (Sigma-Aldrich
Chemie, Steinheim, Germany) according to manufacturer’s
protocol. Allelic discrimination of the
A9285G COL12A1 (rs970547) polymorphic site
was performed using a TaqMan Pre-Designed SNP
Genotyping Assays (Applied Biosystems, Foster
City, CA, USA), including primers and fluorescently
labelled (FAM and VIC) MGB probes for the detection
of the alleles. All samples were genotyped on
a Rotor-Gene real-time polymerase chain reaction
(Re-Ti-PCR) instrument (Corbett Research, Sydney,
NSW, Australia). Thermal cycler conditions were as
follows: an initial step at 95 °C for 5 min., followed
by 45 cycles of denaturation at 94 °C for 15 seconds
and annealing/extension at 60 °C for 1 min.
Statistical Analysis. Any differences in genotype
and allele frequency were analyzed using χ2
tests (or Fisher exact tests). Odds ratios (OR) with
95% confidence intervals (95% CI) were calculated.
All calculations were performed using Statistica
(StatSoft Inc., Tulsa, OK, USA; 2011). STATISTICA
(data analysis software system, version 10, www.statsoft.com) was used for computing statistics,
except Hardy-Weinberg equilibrium which was
tested with the programming language and environment
R (http://www.r-project.org) and the test for
linear trend, which was performed using the STATCALC
module in Epi Info (http://wwwn.cdc.gov/
epiinfo). The p <0.05 values were considered to be
statistically significant.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|